$MPTI
M-tron Industries, Inc. Stock $mpti

$mpti Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000143774924009243 Filed on March 25, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$11.19M	$10.77M	$41.17M
YoY Change	19.41%	24.21%	29.28%
Cost Of Revenue	$6.406M	$6.080M	$24.40M
YoY Change	3.81%	8.96%	35.27%
Gross Profit	$4.779M	$4.693M	$16.77M
YoY Change	49.53%	51.73%	21.44%
Gross Profit Margin	42.73%	43.56%	40.73%
Selling, General & Admin	$2.357M	$4.167M	$10.25M
YoY Change	-3.2%	83.97%	14.81%
% of Gross Profit	49.32%	88.79%	61.14%
Research & Development	$633.0K	$586.0K	$2.216M
YoY Change	19.66%		10.47%
% of Gross Profit	13.25%	12.49%	13.22%
Depreciation & Amortization	$219.0K	$233.0K	$797.0K
YoY Change	12.31%	17.09%	18.78%
% of Gross Profit	4.58%	4.96%	4.75%
Operating Expenses	$633.0K	$4.753M	$2.216M
YoY Change	19.66%	109.85%	10.47%
Operating Profit	$1.789M	-$60.00K	$4.299M
YoY Change	135.09%	-107.25%	49.53%
Interest Expense	$32.00K	$13.00K	$7.000K
YoY Change	-1700.0%	-360.0%	-102.5%
% of Operating Profit	1.79%		0.16%
Other Income/Expense, Net	$74.00K	$113.0K	$101.0K
YoY Change	-276.19%	-148.5%	-136.07%
Pretax Income	$1.863M	$53.00K	$4.400M
YoY Change	159.11%	-91.09%	69.56%
Income Tax	$377.0K	-$20.00K	$911.0K
% Of Pretax Income	20.24%	-37.74%	20.7%
Net Earnings	$1.486M	$73.00K	$3.489M
YoY Change	168.72%	-61.58%	94.05%
Net Earnings / Revenue	13.29%	0.68%	8.48%
Basic Earnings Per Share	$0.55	$0.03	$1.29
Diluted Earnings Per Share	$0.53	$0.03	$1.28
COMMON SHARES
Basic Shares Outstanding	2.796M	2.788M	2.696M
Diluted Shares Outstanding	2.785M		2.734M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.414M	$3.913M	$3.913M
YoY Change	380.39%	322.57%	322.57%
Cash & Equivalents	$5.414M	$3.913M	$3.913M
Short-Term Investments
Other Short-Term Assets	$554.0K	$588.0K	$588.0K
YoY Change	16.88%	-12.63%	-12.63%
Inventory	$9.161M	$8.884M	$8.884M
Prepaid Expenses
Receivables	$5.594M	$4.802M	$4.802M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$20.72M	$18.19M	$18.19M
YoY Change	33.12%	27.06%	27.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.034M	$4.131M	$4.228M
YoY Change	14.28%	13.27%	11.44%
Goodwill	$40.00K	$5.000K
YoY Change		-87.5%
Intangibles	$40.00K	$45.00K
YoY Change		-54.08%
Long-Term Investments
YoY Change
Other Assets	$8.000K	$10.00K	$1.845M
YoY Change	-46.67%	-37.5%	72.91%
Total Long-Term Assets	$6.059M	$6.118M	$6.118M
YoY Change	25.5%	23.37%	23.37%
TOTAL ASSETS
Total Short-Term Assets	$20.72M	$18.19M	$18.19M
Total Long-Term Assets	$6.059M	$6.118M	$6.118M
Total Assets	$26.78M	$24.31M	$24.31M
YoY Change	31.32%	26.11%	26.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.231M	$1.300M	$1.300M
YoY Change	-61.65%	-45.4%	-45.4%
Accrued Expenses	$3.151M	$2.807M	$2.807M
YoY Change	53.71%	25.26%	25.26%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.057M	$4.384M	$4.384M
YoY Change	-9.53%	-9.72%	-9.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$10.00K	$26.00K	$26.00K
YoY Change	-83.05%	-65.79%	-65.79%
Total Long-Term Liabilities	$10.00K	$26.00K	$26.00K
YoY Change	-83.05%	-65.79%	-65.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.057M	$4.384M	$4.384M
Total Long-Term Liabilities	$10.00K	$26.00K	$26.00K
Total Liabilities	$5.067M	$4.410M	$4.410M
YoY Change	-10.3%	-10.58%	-10.58%
SHAREHOLDERS EQUITY
Retained Earnings	$5.187M	$3.701M
YoY Change	578.04%	1645.75%
Common Stock	$16.53M	$16.19M
YoY Change	18.22%	14.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.72M	$19.90M	$19.90M
YoY Change
Total Liabilities & Shareholders Equity	$26.78M	$24.31M	$24.31M
YoY Change	31.32%	26.11%	26.11%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$1.486M	$73.00K	$3.489M
YoY Change	168.72%	-61.58%	94.05%
Depreciation, Depletion And Amortization	$219.0K	$233.0K	$797.0K
YoY Change	12.31%	17.09%	18.78%
Cash From Operating Activities	$1.496M	$2.132M	$4.405M
YoY Change	436.2%	154.72%	115.72%
INVESTING ACTIVITIES
Capital Expenditures	$122.0K	$716.0K	$1.281M
YoY Change	56.41%	162.27%	36.86%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$122.0K	-$716.0K	-$1.281M
YoY Change	56.41%	162.27%	36.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$127.0K	-55.00K	-$137.0K
YoY Change		-87.61%	-95.13%
NET CHANGE
Cash From Operating Activities	$1.496M	2.132M	$4.405M
Cash From Investing Activities	-$122.0K	-716.0K	-$1.281M
Cash From Financing Activities	$127.0K	-55.00K	-$137.0K
Net Change In Cash	$1.501M	1.361M	$2.987M
YoY Change	646.77%	1034.17%	-274.78%
FREE CASH FLOW
Cash From Operating Activities	$1.496M	$2.132M	$4.405M
Capital Expenditures	$122.0K	$716.0K	$1.281M
Free Cash Flow	$1.374M	$1.416M	$3.124M
YoY Change	583.58%	151.06%	182.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	141000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	142000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2786321
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2786321
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2726798
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2726798
CY2023	mpti	Standard And Extended Product Warranty Term StandardAndExtendedProductWarrantyTerm	P1Y
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41391
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-0457944
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2525 Shader Road
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32804
CY2023	dei	City Area Code CityAreaCode	407
CY2023	dei	Local Phone Number LocalPhoneNumber	298-2000
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	MPTI
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	18819073	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2796031
CY2023	dei	Auditor Name AuditorName	PKF O’Connor Davies, LLP.
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023	dei	Auditor Firm AuditorFirmId	127
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41168000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31845000	usd
CY2023	us-gaap	Manufacturing Costs ManufacturingCosts	24402000	usd
CY2022	us-gaap	Manufacturing Costs ManufacturingCosts	20499000	usd
CY2023	mpti	Engineering Selling And Administrative EngineeringSellingAndAdministrative	12467000	usd
CY2022	mpti	Engineering Selling And Administrative EngineeringSellingAndAdministrative	8471000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	4299000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	2875000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-11000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	94000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-269000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	101000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-280000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4400000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2595000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	911000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	797000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3489000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1798000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.67
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.28
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.67
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3913000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	926000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4802000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5197000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	8884000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7518000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	588000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	673000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	18187000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	14314000	usd
CY2023Q4	us-gaap	Land Land	536000	usd
CY2022Q4	us-gaap	Land Land	536000	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	5216000	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	4937000	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	20046000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	19044000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25798000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24517000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21667000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20870000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4131000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3647000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	97000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	147000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	98000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1835000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1051000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16000	usd
CY2023Q4	us-gaap	Assets Assets	24305000	usd
CY2022Q4	us-gaap	Assets Assets	19273000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1300000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2381000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2196000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1627000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	611000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	614000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	277000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	234000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4384000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4856000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	26000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	76000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4410000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4932000	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	27000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	27000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	16167000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14102000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3701000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	212000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	19895000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14341000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24305000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19273000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16849000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1798000	usd
CY2022	mpti	Equity Transfers To Former Parent EquityTransfersToFormerParent	-4386000	usd
CY2022	mpti	Transfer By Former Parent Company To Capital And Paid In Capital TransferByFormerParentCompanyToCapitalAndPaidInCapital	0	usd
CY2022	mpti	Adjustments To Additional Paid In Capital Share Based Compensation And Other AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationAndOther	80000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14341000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3489000	usd
CY2023	mpti	Adjustments To Additional Paid In Capital Transfers To Former Parent AdjustmentsToAdditionalPaidInCapitalTransfersToFormerParent	-219000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2421000	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	137000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	19895000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3489000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1798000	usd
CY2023	us-gaap	Depreciation Depreciation	797000	usd
CY2022	us-gaap	Depreciation Depreciation	671000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	54000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2421000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	458000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-784000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1136000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-395000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1202000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1366000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2297000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-91000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	422000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-691000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1846000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4405000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2042000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1281000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	936000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1281000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-936000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	137000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10000	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	4120000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1300000	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	4120000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1300000	usd
CY2023	mpti	Net Transfers From To Former Parent NetTransfersFromToFormerParent	0	usd
CY2022	mpti	Net Transfers From To Former Parent NetTransfersFromToFormerParent	-309000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	-0	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	20000	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	-0	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2476000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-137000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2815000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2987000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1709000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	926000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2635000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3913000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	926000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1629000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	36000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	6000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	9000	usd
CY2023	mpti	Number Of Subsidiaries NumberOfSubsidiaries	2	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Uses of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of the Consolidated and Combined Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023	us-gaap	Depreciation Depreciation	797000	usd
CY2022	us-gaap	Depreciation Depreciation	671000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	58000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	5000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	40000	usd
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	44
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2733502
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2676524
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2216000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2006000	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2670000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2696445
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2676480
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	37057
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Concentration Risks</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the year ended <em style="font: inherit;"> December 31, 2023</em>, the Company's largest customer accounted for $12,921,000, or 31.4%, of the Company's total revenues, compared to $8,190,000, or 25.7%, of the Company’s total revenues for the year ended <em style="font: inherit;"> December 31, 2022</em>. The Company’s <em style="font: inherit;">second</em> largest customer for the year ended <em style="font: inherit;"> December 31, 2023</em> accounted for $7,822,000, or 19.0%, of the Company's total revenues, compared to $4,857,000, or 15.3%, of the Company’s total revenues for the year ended <em style="font: inherit;"> December 31, 2022</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A significant portion of the Company's accounts receivable is concentrated with a relatively small number of customers. As of <em style="font: inherit;"> December 31, 2023</em>, four of the Company's largest customers accounted for approximately $3,774,000, or 76.4%, of accounts receivable. As of <em style="font: inherit;"> December 31, 2022</em>, four of the Company's largest customers accounted for approximately $2,872,000, or 53.8%, of accounts receivable. The Company carefully evaluates the creditworthiness of its customers in deciding to extend credit and utilizes letters of credit to further limit credit risk for export sales. As a result of these policies, the Company has experienced very low historical bad debt expense and believes the related risk to be minimal.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At various times throughout the year and at <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022</em>, some deposits held at financial institutions were in excess of federally insured limits. The Company has mitigated its risk through placing excess cash balances in a US Treasury money market fund and has <em style="font: inherit;">not</em> experienced any losses related to these balances.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-71000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-82000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1268000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1318000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3594000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3335000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3805000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3173000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1485000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1010000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	8884000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7518000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3966000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1705000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	434000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	890000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4400000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2595000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1308000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	703000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	314000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	188000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	72000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	213000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1694000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1104000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-662000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-263000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-121000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-78000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	34000	usd
CY2023	mpti	Deferred Income Tax Expense Benefit Net DeferredIncomeTaxExpenseBenefitNet	-783000	usd
CY2022	mpti	Deferred Income Tax Expense Benefit Net DeferredIncomeTaxExpenseBenefitNet	-307000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	911000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	797000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	924000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	544000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	143000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	91000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	14000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	83000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	201000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	61000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	55000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	161000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	5000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-29000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-21000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	911000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	797000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.207	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.307	pure
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	306000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	320000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	307000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	181000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	0	usd
CY2023Q4	mpti	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	855000	usd
CY2022Q4	mpti	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	432000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	43000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	399000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	39000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	80000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	540000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	61000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	173000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	23000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	84000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	36000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	33000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	50000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2257000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	422000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1167000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	116000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1835000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1051000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	111000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	77000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	448000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	27000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	-0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	61000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	77000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Acquisition UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition	-0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Acquisition UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition	448000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	111000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	77000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	111000	usd
CY2023Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	33000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	270000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	349000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	97000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	147000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.076	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.063	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	73000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	30000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	103000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	97000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y14D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.58	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.31	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0455	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0332	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y6M
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9710
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.1
CY2022Q4	mpti	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	4.02
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9710
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.1
CY2022Q4	mpti	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	4.02
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	183300
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	36.06
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.98
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	193010
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.9
CY2023Q4	mpti	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	10.63
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y10M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	219400	usd
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.50	pure
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06	pure
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	162000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	89000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9367000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10140000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10888000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10773000	usd
CY2023Q1	us-gaap	Manufacturing Costs ManufacturingCosts	6171000	usd
CY2023Q2	us-gaap	Manufacturing Costs ManufacturingCosts	5921000	usd
CY2023Q3	us-gaap	Manufacturing Costs ManufacturingCosts	6230000	usd
CY2023Q4	us-gaap	Manufacturing Costs ManufacturingCosts	6080000	usd
CY2023Q1	mpti	Engineering Selling And Administrative EngineeringSellingAndAdministrative	2435000	usd
CY2023Q2	mpti	Engineering Selling And Administrative EngineeringSellingAndAdministrative	2654000	usd
CY2023Q3	mpti	Engineering Selling And Administrative EngineeringSellingAndAdministrative	2625000	usd
CY2023Q4	mpti	Engineering Selling And Administrative EngineeringSellingAndAdministrative	4753000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	761000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1565000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	2033000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-60000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2000	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-5000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1000	usd
CY2023Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	13000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-40000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	22000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12000	usd
CY2023Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	100000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-42000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13000	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	113000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	719000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1582000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2046000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	53000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	166000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	305000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	460000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-20000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	553000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1277000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1586000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	73000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.2
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7691000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7064000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8417000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8673000	usd
CY2022Q1	us-gaap	Manufacturing Costs ManufacturingCosts	4819000	usd
CY2022Q2	us-gaap	Manufacturing Costs ManufacturingCosts	4412000	usd
CY2022Q3	us-gaap	Manufacturing Costs ManufacturingCosts	5688000	usd
CY2022Q4	us-gaap	Manufacturing Costs ManufacturingCosts	5580000	usd
CY2022Q1	mpti	Engineering Selling And Administrative EngineeringSellingAndAdministrative	2058000	usd
CY2022Q2	mpti	Engineering Selling And Administrative EngineeringSellingAndAdministrative	2049000	usd
CY2022Q3	mpti	Engineering Selling And Administrative EngineeringSellingAndAdministrative	2099000	usd
CY2022Q4	mpti	Engineering Selling And Administrative EngineeringSellingAndAdministrative	2265000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	814000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	603000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	630000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	828000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1000	usd
CY2022Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-5000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15000	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-228000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16000	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-233000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	794000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	592000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	614000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	595000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	175000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	106000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	405000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	619000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	486000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	503000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	190000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07

Files In Submission

Name	View Source	Status
0001437749-24-009243-index-headers.html	Edgar Link	pending
0001437749-24-009243-index.html	Edgar Link	pending
0001437749-24-009243.txt	Edgar Link	pending
0001437749-24-009243-xbrl.zip	Edgar Link	pending
ex_572216.htm	Edgar Link	pending
ex_572217.htm	Edgar Link	pending
ex_572218.htm	Edgar Link	pending
ex_572219.htm	Edgar Link	pending
ex_628201.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mpti-20231231.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mpti-20231231_def.xml	Edgar Link	unprocessable
mpti20221231_10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
mpti-20231231_pre.xml	Edgar Link	unprocessable
mpti20221231_10k_htm.xml	Edgar Link	completed
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mpti-20231231_cal.xml	Edgar Link	unprocessable
mpti-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MPTI
M-tron Industries, Inc. Stock $mpti

2024 Q1 Form 10-K Financial Statement

#000143774924009243 Filed on March 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPTI M-tron Industries, Inc. Stock $mpti

2024 Q1 Form 10-K Financial Statement

#000143774924009243 Filed on March 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPTI
M-tron Industries, Inc. Stock $mpti